Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset - Concepedia

Concepedia

Publication | Open Access

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset

DOI Full Paper Access

41

Citations

40

References

2022

Year

Irene Veneziani, Claudia Alicata, Andrea Pelosi, Nadine Landolina, Biancamaria Ricci, Valentina Doria, Anna Fagotti, Giovanni Scambia, Lorenzo Moretta, Enrico Maggi

Journal for ImmunoTherapy of Cancer

Abstract

These data highlight the potential value of TLR8 in NK cells as a new target for immunotherapy in patients with cancer.

References

	Year	Citations

Page 1